Mavens Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 16	Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12

Sources of funds

Owner's fund

Equity share capital

10.99

10.99

10.99

10.99

10.99

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

8.23

8.15

8.12

8.05

7.35

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

19.22

19.14

19.11

19.05

18.34

Uses of funds

Fixed assets

Gross block

7.26

7.25

7.25

7.25

7.25

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

3.03

2.88

2.51

2.29

2.01

Net block

4.22

4.37

4.74

4.96

5.24

Capital work-in-progress

1.44

1.44

1.44

1.44

1.44

Investments

0.42

0.42

0.42

0.42

0.42

Net current assets

Current assets, loans & advances

13.48

13.22

12.81

12.61

11.69

Less : current liabilities & provisions

0.34

0.31

0.30

0.38

0.45

Total net current assets

13.14

12.91

12.51

12.23

11.24

Miscellaneous expenses not written

-

-

-

-

-

Total

19.22

19.14

19.11

19.05

18.34

Notes:

Book value of unquoted investments

-

-

0.42

0.42

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.35

-

-

-

-

Number of equity sharesoutstanding (Lacs)

1099.20

1099.20

1099.20

1099.20

1099.20